Furthermore, what is not clear from previous studies is how, given its proposed direct block of TREK-1 channels, spadin specifically affects depression with little impact on pain, epileptogenesis or cardiac phenotypes, raising questions about its mechanism of action. The gene discussed is KCNK2; the disease is depressive symptom measurement.